Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
AAO 2025: Retinal manifestations of antipsychotic medications | Ophthalmology Times
Sharon Fekrat, MD, FACS, FASRS, shared insights at the American Academy of Ophthalmology (AAO) 2025 meeting in Orlando on the retinal manifestations of antipsychotic medications—a topic with important clinical implications for retina specialists. Antipsychotic drugs, used to treat conditions such…
Throwback Series: Learning when to intervene surgically in glaucoma | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, leaders in ophthalmology revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way such cases are managed…
Systemic chemotherapy reduces mortality in retinoblastoma: 30-year analysis from Iran | Ophthalmology Times
(Image Credit: AdobeStock/Sherry Young) A new study in the International Journal of Retina and Vitreous reported that use of systemic chemotherapy as a mainstay of treatment for retinoblastoma results in significant decreases in mortality and morbidity. Adding targeted chemotherapy reduced…
The mechanics of presbyopia: From muscle movement to functional vision | Ophthalmology Times
(Image Credit: AdobeStock) Presbyopia-correcting eye drops share a common mechanism: They are miotic agents designed to create a smaller pupil. The power of the pupil to extend depth of focus is impressive, as observed in patients with smaller pupils who…
Subretinal drusenoid deposits in Black and Hispanic patients with AMD | Ophthalmology Times
(Image Credit: Adobestock/Alessandro Grandini) Researchers from New York Eye and Ear Infirmary of Mount Sinai, New York, reported that subretinal drusenoid deposits (SDDs) in patients with age-related macular degeneration (AMD) who are Black or Hispanic may indicate that they are…
Throwback Series: Identifying and treating neovascular lesions in pregnancy | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, we invited leaders in ophthalmology to revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way…
Starting from scratch on neovascular age-related macular degeneration | Ophthalmology Times
(Image Credit: AdobeStock) Luis Arias, MD; and Paolo Lanzetta, MD, recently found themselves on opposite sides of the debate table regarding the value of gene therapy to treat neovascular age-related macular degeneration (nAMD) at the 16th Annual Congress on Controversies…
Rethinking punctal occlusion as an option for allergic conjunctivitis | Ophthalmology Times
(Image Credit: AdobeStock) The intracanalicular dexamethasone ophthalmic insert (Dextenza; Ocular Therapeutix) incorporates 0.4 mg of dexamethasone into the hydrogel matrix to treat postoperative inflammation and pain following ocular surgery. It is also approved for the treatment of ocular itching associated…
AAO 2025: Understanding and diagnosing endophthalmitis | Ophthalmology Times
Note: Video captions are generated with the assistance of AI and may contain errors. At the 2025 annual meeting of the American Academy of Ophthalmology, Sunir J. Garg, MD, gave a presentation titled, “Endophthalmitis Sterile or not.” In an interview…
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg | Ophthalmology Times
Note: Video captions are generated with the assistance of AI and may contain errors. Diana Do, MD, a professor of ophthalmology and vice chair of Clinical Affairs at Stanford University’s Byers Eye Institute, presented research on aflibercept 8 mg in…